Can the use of long-acting injectable antipsychotic preparations be increased in routine clinical practice and the benefits realised?

• Päätekijät: Carol Paton (Tekijä), Chike I. Okocha (Tekijä), Maxine X. Patel (Tekijä)
• Aineistotyyppi: Kirja
• Julkaistu: SAGE Publishing, 2022-02-01T00:00:00Z.
• Aiheet: article
• Linkit: Connect to this object online.

Background: The use of continuing antipsychotic medication is an established evidence-based strategy for preventing relapse in people with schizophrenia, but medication adherence is known to be suboptimal. Covert non-adherence can be eliminated by the use of long-acting injectable (LAI) formulations...